Trial reportThe Canadian veterinary journal = La revue veterinaire canadienne2017
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Trial report in The Canadian veterinary journal = La revue veterinaire canadienne, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.Archives of Razi Institute · 2021Pooled it
- Maropitant administered orally 2-2.5 h prior to morphine and dexmedetomidine reduces the incidence of emesis in cats.Journal of feline medicine and surgery · 2017Trial
- Incidence of Post-Sedation Emesis in Cynomolgus (Animals : an open access journal from MDPI · 2025Article
- Use of erythromycin and metoclopramide in hospitalized dogs: a multicenter historical cohort study.Frontiers in veterinary science · 2025Article
- Ophthalmic ropinirole is an equally effective emetic agent in healthy dogs compared to intravenous apomorphine.Frontiers in veterinary science · 2025Article
- Plasma Concentrations of Oral Ondansetron in Hospitalized Dogs Exhibiting Clinical Signs of Nausea.Veterinary sciences · 2024Article
- Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.Journal of veterinary internal medicine · 2022Article
- The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.BMC veterinary research · 2021Article
- Continuous Infusion of Ketamine and Lidocaine Either with or without Maropitant as an Adjuvant Agent for Analgesia in Female Dogs Undergoing Mastectomy.Veterinary medicine international · 2021Article
- Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care.Scientific reports · 2020Article
- The effect of intravenous maropitant on blood pressure in healthy awake and anesthetized dogs.PloS one · 2020Article
- Article
- Assessment of Dog Owner Concern Regarding Peri-operative Nausea and Vomiting and Willingness to Pay for Anti-emetic Treatment.Frontiers in veterinary science · 2019Article
- Spotlight on the perioperative use of maropitant citrate.Veterinary medicine (Auckland, N.Z.) · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Morphine is widely used as a preanesthetic agent in dogs, but it often produces signs of nausea and vomiting. Maropitant (MRP) and metoclopramide (MCP) prevent emesis attributable to the opioid agent apomorphine in dogs. We evaluated the antiemetic efficacy and the discomfort in response to SQ injection of MRP [1 mg/kg body weight (BW)], MCP (0.5 mg/kg BW), and normal saline (SAL; 0.1 mL/kg BW) administered to 63 dogs, 45 minutes prior to morphine (0.5 mg/kg BW) and acepromazine (0.05 mg/kg BW). Dogs were observed for signs of nausea (ptyalism, lip licking, and increased swallowing) and vomiting for 30 minutes after morphine/acepromazine. The incidence of emesis was 0% for MRP, 38% for MCP, and 71% for SAL (
Indexed as
Identifiers
28042152PMC5157735W2584272983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.